GlassScriptPhysician profile
You You
NPI 1750279444
$969.49
in general payments reported to CMS, 2019-2025
14 companies · $969 in 2025
The $969 reported for 2025 was more than what 86% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $189.16 | 2025 | Rezdiffra |
| Axsome Therapeutics, INC. | $154.97 | 2025 | Symbravo |
| Amgen INC. | $153.09 | 2025 | Evenity, Repatha, Otezla |
| Ardelyx, INC. | $111.57 | 2025 | Ibsrela |
| Bayer Healthcare Pharmaceuticals INC. | $101.49 | 2025 | |
| Genzyme Corporation | $45.56 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $42.20 | 2025 | Fasenra, Breztri |
| Regeneron Healthcare Solutions, INC. | $36.81 | 2025 | Dupixent |
| Kowa Pharmaceuticals America, INC. | $33.15 | 2025 | Zoryve |
| Sumitomo Pharma America, INC. | $24.65 | 2025 | Gemtesa |
| Radius Health, INC. | $22.29 | 2025 | Tymlos |
| Sun Pharmaceutical Industries INC. | $19.45 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.57 | 2025 | Xifaxan |
| Corcept Therapeutics | $17.53 | 2025 | Korlym |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw You You listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.